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Estimation ofTime-Related Features of the Central Pressure 
Pulse From the Radial Artery Pressure 
Waveform 1159.164*256A 
Reduction of Left Ventricular Hypertrophy (LVH) by 
Anrihyperrensive Therapy: Results of a Meta-Analysis 
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Injury in Rabbits: a Semiquntitation of Reverse 
Transcription-Polymerase Chain Reaction 
Analysis 1230-187*284A 
Effect of Sildenafil (Viagram) on Wave Reflection: A New 
Insight Into its Cardiovascular Effects 1163.185*26OA 
Endovzscular Stat-Grafts Implantation for Descending 
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Reduction in Aortic Plaque Burden in Patients With 
Familial Hyperlipidemia as Assessed by 
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Is the Need for Re-Intervention Higher With Percutaneous 
Coronxy Interventions or With Coronary Artery 
Bypass Surgery! 1296.34.82A 
Multivessel Srenting: Is It Time to Reconsider 
Recommendations for Coronary Artery Bypass 
Surgely? 1189.21*51A 
Myocardia Release ofP-Selectin Following Ischemia 
During Beating Heart Coronary Artery Bypass 
Surgety 1017.84.309A 
Outcome of Patients With Acute Coronary Syndromes 
With and Without Prior CABG: Results From the 
PURSUITTrial 1154.102*341A 
Percutaneous Coronary Intervention Versus Coronary 
Bypass Graft Surgery: Outcome of Diabetics in the 
AWESOME Randomized Trial and 
Registry 1150.80*336A 
Pressure-Flow Relationship in Coronary Bypass Grafts Early 
After Myocardial Rwascularisation 1017.86.309A 
Prospective Ten-Year Patency of Saphenous Vein and Left 
Internal Mammary Artery Grafts After Coronary 
Artery Bypass Surgery 883.1*37OA 
Randomized Trial ofPropafenone, Ibutilide, or Rate Control 
in Post operative Atrial Fibrillation 1300.12p139A 
Risk-Adjusted Survival After Coronary Artery Bypass 
Surgery Compared to Coronary Stenting 860.1*67A 
Apolipoproteins 
Serial, Non-invasive, High Resolution Magnetic Resonance 
Microscopy Measures Progression of Atherosclerosis in 
Apolipoprotein E Deficient Mice 1032.13t+38OA 
The Effects of Simvasratin and Atorvasratin on HDL 
Subfractions 842.5*263A 
Apoptosis 
Antiapoptotic Effects of Carvedilol Are Not Mediated by Its 
Beta-Adrenergic Receptor Blocking 
Properties 1016.79.3OSA 
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Chronic Therapy With the Acorn Cardiac Support Device 
(CSD) Attenuates Cardiomyocyte Apoptosis in Dogs 
With Heart Failure 815.5.478A 
Cyclosporin A Inhibits Cytochrome c Release and Prevents 
Myocardial Cell Death Induced by Ischemia/ 
Reperfusion 1183.8@346A 
Discordant Regulation of Apoprosis Associated Proteins in 
Cardiomyocytes Isolated From Patients With Ischemic 
Versus Idiopathic Dilated 
Cardiomyopathy 1135.71*17OA 
Distinct Signaling Pathways Account for Endothelial and 
Myocardial Apoptosis During Ischaemia-Reperfwion 
Injury 1016.83*309A 
Effects of Atorvastatin Treatment on Global Fibrinolytic 
Capacity, Apoptosis, and Leukocyre Activation in 
Patients With Coronary Artcry 
Disease 1007-202267A 
Effects of Biventricular Pacing on Cardiac Myocytes 
Apoptosis 857.5.119A 
Exposure of Cardiomyocytes From Failing Explanted 
Human Heart to Hypoxia and/or Angiotensin-II Leads 
to Activation of Caspase-3 and to Cleavage of DNA 
Fragmentation Factor (DFF45/ICAD) 854.5.192A 
Goats in Chronic Atria1 Fibriiarion Show Apoptotic Atrial 
Myocytes and BCL-2 Upregulation in Ventricular 
Myocytes 1237.115.12OA 
In Vivo Determination of Cell Death Within the Area at 
Risk in Patients With Acute Myocardial 
Infarction 1175.139.411A 
Increased DNA Content and Transcriptional Activity in 
M yocytes From Pressure Overloaded Human 
Myocardium 1197.74*186A 
Hypertensive Subjects With Normal Left Ventricular 
Mass 1193.172.271A 
Dyslipidemia Is a Risk Factor for Aortic Atherosclerosis: A 
Population-Based Transesophageal Echocardiographic 
Study 859-5*278A 
Echocardiographic Predictors of Abdominal Aortic 
Aneurysm: The Cardiovascular Health 
Study 1144.150.404A 
Elevated Plasma Level ofAsymmetric Dimethylarginine 
(ADMA) Is Associated With Atherosclerotic Disease 
of the Thoracic Aorta 130&187*3OlA 
Intravascular Ultrasound Assessment of Abdominal Aortic 
Aneurysm 1257.34.74A 
Mortality in Type B Acute Aortic Dissections in the Current 
Era: Results From the International Registry of Aortic 
Dissection (IRAD) 1280.7t514A 
Percutaneous Placement of Abdominal Aortic Stem Grafts: 
Is There a Role for Intravascular Ultrasound 
Guidance? 1092.159.234A 
Predicting In-Hospital Mortality in Acute Type A Aortic 
Dissection: Lessons From the International Registry of 
Aortic Dissection (IRAD) 1002.201.492A 
The Association of Ventricular Septal Defect and Dilated 
.4ortic Root 1082.200.459A 
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During Myocardiai Infarction but Not After 
Stunning 1016-80.308A 
Ischemic Preconditioning Prevents Mitochondrial Bcl-2 
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Prevents In-Stat Restenosis in Atheromatous Rabbits: 
A Potential Strategy for Therapeutic Angiogenesis via 
Vascular Endarhelial Growth Factor 1187.42.49A 
Clinical and Angiogmphic Results of l-Year Follow-Up 
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(VEGF) A, B, C, and their Receptors in Human 
Atherosclerotic Arteries 107%188*232A 
Modest Efficacy of Folic Acid and the Lack of an Additional 
Effect of Vitamin B12 in Hyperhomocystinaemic 
Patients With Coronary Artery Disease 895->303A 
No Clear Role for the -159T/C Polymorphism of the CD14 
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Mechanjsm of Enhanced Susceptibility of Hyperrrophied 
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Inertia of Left Ventricular End-Ejection Flow Speeds the 
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Co&) 1297.113*135A 
Utility of Electrophysiologic Testing in Patients with 
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Mechanism of VF Reinitiation After Failed Defibiiation 
Shocks: An Optical Mapping Study in Isolated Swine 
Hearts 1297-112.13511 
Open Chest DetibrZlauon: Blphasic Vewz Monophasic 
Waveform Shocks 1084.83*32OA 
The Role of Structural Complexities of the Sepal Tissue in 
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Circulatory Dimensions but Not to Ejection Fraction in 
Normal Subjects 1067.148~388A 
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Right Ventricle Diastolic Dysfunction in Systemic 
Hypertension, a Common Finding 1127.167%7A 
Right Ventricular Cardiomyoplasty for the Treatment of 
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RSR’ Pattern Without the Evidence of Bundle Branch 
Block: Diagnostic V&e as a Sign of Left Ventricular 
Aneurysm 1285.91*375A 
Serial Changes of Left Ventricular Function in Dogs 
Following Myocardial Ischemia-Rep&i&n Injury: A 
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Remodeling 1132.52*166A 
Urotensin II Stimulates Collagen Synthesis by Cardiac 
Fibroblasts and Hypertrophic Signalling in 
Cardiomyocytes via G(alpha)q- and Ras-Dependent 
Pathways 822.5.164A 
V&&-Ventricular Remodeling and Mitral Leaflet 
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Mutation 1027-117*87A 
Simultaneous Endocardiai and Epicardial Microelectrode 
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